Ophthalmic Drugs Contract Manufacturing Market Trends 2019 and Industry Forecast 2030


Posted July 22, 2020 by Stella01wilson

More than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation
 
Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource certain aspects of drug development and production operations to contract service providers.

The USD 1.7 billion financial opportunity (by 2030) within the Ophthalmic Drugs Contract Manufacturing Market has been analyzed across the following segments:

Type of product
• Ophthalmic API
• Ophthalmic drug FDF

Type of FDF manufactured
• Solid
• Semi-solid
• Liquid / suspension

Type of primary packaging
• Ampoule / vial
• Glass / plastic bottle
• Ointment tube
• Blister packing
• Other forms

Scale of manufacturing
• Clinical
• Commercial

Company size
• Small
• Mid-sized
• Large
• Very large

Target disease indication
• Age-related macular degeneration
• Dry eye
• Glaucoma
• Other disease segments

Key geographical regions
• North America (US, Canada and Mexico)
• Europe (UK, Germany, France, Spain, Italy and rest of Europe)
• Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)
• Rest of the world

For more information, please visit https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

The Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030 report features the following companies, which we identified to be key players in this domain:
• Akorn
• Akums
• Bal Pharma
• Catalent
• Cayman Chemical
• Entod Pharmaceuticals
• Farmigea
• Glenmark Pharmaceuticals
• Indiana Ophthalmics
• Lomapharm
• Medichem
• Pillar5 Pharma
• Recipharm
• Salvat
• Sterling Pharmaceutical Services
• Sunways India

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Current Market Landscape
5. Company Competitiveness Analysis
6. Ophthalmic Drugs Contract Manufacturing in North America: Company Profiles
7. Ophthalmic Drugs Contract Manufacturing in Europe: Company Profiles
8. Ophthalmic Drugs Contract Manufacturing in Asia-Pacific: Company Profiles
9. Clinical Trial Analysis
10. Capacity Analysis
11. Demand Analysis
12. Market Forecast
13. Case Study: Comparison of Small Molecule and Large Molecule Ophthalmic Drugs / Therapies
14. SWOT Analysis
15. Survey Analysis
16. Executive Insights
17. Future Growth Opportunities
18. Appendix 1: List of Ophthalmic Medical Device Contract Manufacturers
19. Appendix 2: Tabulated Data
20. Appendix 3: List of Companies and Organizations

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Roots Analysis
Phone 4158003415
Business Address Sacramento Los Angeles Beverly Hills
Country United States
Categories Business , Industry , Research
Tags ophthalmic drugs contract manufacturing , ophthalmic drugs contract manufacturing market , ophthalmic drugs contract manufacturing market size
Last Updated July 22, 2020